Many preschoolers with ADHD receive medication before behavioral therapy

Many preschoolers with ADHD receive medication before behavioral therapy

[ad_1] Young children with attention deficit/hyperactivity disorder often receive medication just after being diagnosed, which contravenes treatment guidelines endorsed by the American Academy of Pediatrics, a Stanford Medicine-led study has found. The finding, which will be published Aug. 29 in JAMA Network Open, highlights a gap in medical care for 4- and 5-year-olds with ADHD….

Read More
Children in low-opportunity neighborhoods face much higher risk of gun injuries

Children in low-opportunity neighborhoods face much higher risk of gun injuries

[ad_1] Children residing in “very low-opportunity” neighborhoods are up to 20 times more likely to be hospitalized for gun injuries than those living in the most advantaged areas, reports a new multi-state study published in Pediatrics. The study also found that most hospitalizations for gun injuries among children under 18 are the result of unintentional…

Read More
Computational approach provides insight into neural progenitor cells and their role in brain disorders

Computational approach provides insight into neural progenitor cells and their role in brain disorders

[ad_1] For much of the 20th century it was thought that the adult brain was incapable of regeneration. This view has since shifted dramatically and neurogenesis – the birth of new neurons – is now a widely accepted phenomenon in the adult brain, offering promising avenues for treating many neurological conditions. One of the main…

Read More
Breakthrough in protein drug delivery could replace lengthy IV infusions

Breakthrough in protein drug delivery could replace lengthy IV infusions

[ad_1] Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these protein therapeutics require high doses to be effective and are typically formulated at low concentrations to remain stable, IV infusion has been, until now, the only option. Researchers at Stanford…

Read More
Kennedy’s anti-vaccine strategy risks forcing shots off market, manufacturers warn

Kennedy’s anti-vaccine strategy risks forcing shots off market, manufacturers warn

[ad_1] Dining under palm trees on a patio at Mar-a-Lago in December, President-elect Donald Trump reassured chief executives at pharmaceutical giants Eli Lilly and Pfizer that anti-vaccine activist Robert F. Kennedy Jr. wouldn’t be a radical choice to head the Department of Health and Human Services. “I think he’s going to be much less radical…

Read More
School connectedness protects adolescents from depression linked to bullying

School connectedness protects adolescents from depression linked to bullying

[ad_1] School connectedness buffers against depression symptoms associated with being a victim of peer bullying in adolescence, according to a study published in BMC Public Health. School connectedness was measured by the degrees of inclusiveness, closeness, happiness and safety of adolescents within the school environment. We found that peer bullying during adolescence was associated with…

Read More
Texas Children’s successfully treats AADC deficiency using FDA-approved gene therapy

Texas Children’s successfully treats AADC deficiency using FDA-approved gene therapy

[ad_1] Texas Children’s is pleased to announce that a three-year-old girl has been successfully treated with the first-ever FDA-approved gene therapy treatment for AADC deficiency.  Aromatic l-amino acid decarboxylase (AADC) deficiency is an extremely rare, inherited neurological disorder that prevents the brain from producing dopamine and serotonin – essential chemicals for controlling movement, mood and…

Read More
Early use of risdiplam in newborns with SMA shows improvements in motor development

Early use of risdiplam in newborns with SMA shows improvements in motor development

[ad_1] Spinal muscular atrophy (SMA) is a rare genetic condition that causes progressive muscle weakness, which, when untreated, prevents infants with the most severe form from gaining motor development – never gaining the ability to sit – and typically leads to death before 2 years of age. The oral drug risdiplam benefits symptomatic patients with…

Read More